Each month the Lupus Forum Steering Committee selects the latest published original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.
Literature Highlights - April 2024
Keywords:
Anifrolumab, Mycophenolate mofetil, Sm-Tregs, CAR T-Cell, CV Risk factors,Literature Highlights - January 2024
This highlight deck is comprised of 5 papers
Keywords:
Telitacicept, Fatigue, Digital tools, Burden of disease, IFNGS, Glucocorticoid tapering, Economic insecurities, PROsLiterature Highlights - December 2023
This highlight deck is comprised of 3 papers
Keywords:
Obinutuzumab, NOBILITY, Lupus nephritis, Telitacicept, Real-world, Hydroxychloroquine, SLICC, Disease flareLiterature Highlights - November 2023
This highlight deck is comprised of 4 papers
Keywords:
EULAR, Cutaneous lupus erythematosus, Lupus nephritis, Anifrolumab, Real-worldLiterature Highlights - October 2023
This highlight deck is comprised of 5 papers
Keywords:
Immunosuppressants, Flares, Lupus nephritis, EULAR, CV eventsLiterature Highlights - September 2023
This highlight deck is comprised of 7 papers
Keywords:
Therapeutic strategies, Belimumab, Glucocorticoids, Disease activity, PROs, Remission, Physician global assessment, Chronic kidney disease, In-hospital mortality, BILAG, QoL, LLDAS,Literature Highlights - August 2023
This highlight deck is comprised of 4 papers